Physician profile
Michael C Cunningham
NPI 1821219106
$44,669.84
in general payments reported to CMS, 2019-2025
51 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,567 · 2020: $1,814 · 2021: $3,744 · 2022: $12K · 2023: $2,476 · 2024: $5,205 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $8,622 · Debt Forgiveness: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,019.99 |
| Food and Beverage | $8,622.41 |
| Debt Forgiveness | $824.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,118.26 | 2021-2025 | Corevalve Evolut R, Mo.Ma Ultra, Micra |
| Edwards Lifesciences Corporation | $4,659.06 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $4,280.67 | 2019-2020 | |
| Boston Scientific Corporation | $2,971.29 | 2019-2025 | General - Structural Heart, Watchman Access System, Versacross Large Access Solution |
| Abbott Laboratories | $1,436.95 | 2019-2025 | Esprit, Diamondback Coronary, Jot Dx |
| Silk Road Medical, INC. | $1,395.55 | 2021 | |
| Abiomed | $1,169.70 | 2019-2025 | Impella |
| Inari Medical, INC. | $968.27 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $936.12 | 2019-2025 | |
| Lantheus Medical Imaging, INC. | $824.00 | 2025 | Definity |
| Janssen Pharmaceuticals, INC | $712.41 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $693.50 | 2021-2025 | Verquvo |
| Pfizer INC. | $569.14 | 2019-2025 | |
| Endologix LLC | $548.36 | 2024-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| E.R. Squibb & Sons, L.L.C. | $522.78 | 2019-2025 | Camzyos, Eliquis |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $504.28 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Amgen INC. | $325.21 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $282.93 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Recor Medical INC | $264.86 | 2024 | Paradise Renal Denervation System |
| Esperion Therapeutics, INC. | $248.92 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.07 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $151.20 | 2021-2025 | Kengreal, Cleviprex |
| Ge Healthcare | $147.45 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.45 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $143.65 | 2020-2024 | Wainua, Farxiga |
| Truvic Medical, INC. | $134.61 | 2022 | |
| Imperative Care, INC | $130.10 | 2023-2024 | Symphony Catheter |
| Lexicon Pharmaceuticals, INC. | $121.36 | 2024 | Inpefa |
| Baxter Healthcare | $115.97 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $112.27 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $96.33 | 2019 | |
| Irhythm Technologies, INC. | $95.56 | 2024 | Zio Monitor, Zio Xt Patch |
| Bard Peripheral Vascular, INC. | $84.89 | 2025 | |
| Philips North America LLC | $79.89 | 2019 | |
| Cardiovascular Systems INC. | $71.51 | 2021-2022 | |
| Penumbra, INC. | $71.15 | 2025 | Penumbra System, Indigo System |
| Atricure, INC. | $64.25 | 2021-2023 | |
| Gilead Sciences, INC. | $41.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.07 | 2023-2025 | |
| Terumo Medical Corporation | $30.18 | 2021-2023 | Angio-Seal |
| Heartflow, INC. | $26.58 | 2022 | |
| Scpharmaceuticals INC. | $24.46 | 2025 | |
| Itamar Medical INC | $22.21 | 2023 | Watchpatone |
| Saranas, INC. | $21.39 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $16.58 | 2021 | |
| Novo Nordisk INC | $16.01 | 2023 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $15.54 | 2022 | |
| Amarin Pharma, INC. | $15.41 | 2019 | |
| Biotronik INC. | $13.17 | 2024 | Amvia Edge |
| Biocompatibles, INC. | $12.33 | 2019 | |
| Medicomp INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.